Sentry Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-357
Closed -$86K 393
2025
Q4
$86K Hold
357
0.06% 266
2025
Q3
$101K Sell
357
-65
-15% -$17.8K 0.07% 242
2025
Q2
$108K Hold
422
0.06% 271
2025
Q1
$90K Sell
422
-126
-23% -$29.4K 0.06% 269
2024
Q4
$125K Sell
548
-89
-14% -$21.4K 0.06% 262
2024
Q3
$156K Hold
637
0.07% 260
2024
Q2
$122K Sell
637
-131
-17% -$26.6K 0.05% 284
2024
Q1
$152K Hold
768
0.06% 282
2023
Q4
$132K Sell
768
-83
-10% -$12.8K 0.06% 293
2023
Q3
$126K Sell
851
-117
-12% -$21.2K 0.06% 301
2023
Q2
$212K Hold
968
0.08% 255
2023
Q1
$212K Hold
968
0.09% 244
2022
Q4
$201K Sell
968
-25
-3% -$5.49K 0.09% 246
2022
Q3
$217K Hold
993
0.1% 209
2022
Q2
$208K Sell
993
-193
-16% -$41.1K 0.09% 221
2022
Q1
$288K Sell
1,186
-200
-14% -$48.4K 0.09% 222
2021
Q4
$361K Hold
1,386
0.09% 220
2021
Q3
$365K Sell
1,386
-202
-13% -$55.2K 0.11% 207
2021
Q2
$391K Hold
1,588
0.1% 211
2021
Q1
$308K Sell
1,588
-7,573
-83% -$1.52M 0.09% 244
2020
Q4
$1.95M Hold
9,161
0.1% 205
2020
Q3
$1.57M Hold
9,161
0.09% 214
2020
Q2
$1.76M Buy
9,161
+967
+12% +$158K 0.11% 191
2020
Q1
$1.21M Hold
8,194
0.09% 206
2019
Q4
$1.27M Hold
8,194
0.08% 254
2019
Q3
$1.11M Hold
8,194
0.07% 258
2019
Q2
$1M Hold
8,194
0.07% 287
2019
Q1
$852K Buy
+8,194
New +$846K 0.06% 302
2018
Q2
Sell
-9,772
Closed -$962K 485
2018
Q1
$962K Sell
9,772
-939
-9% -$88.7K 0.06% 326
2017
Q4
$907K Hold
10,711
0.05% 348
2017
Q3
$824K Buy
+10,711
New +$819K 0.03% 364

Other funds holding RMD

Sentry Investment Management's RMD Position: Q1 2026 in Review

Sentry Investment Management sold out of ResMed (RMD) in Q1 2026, closing a stake of 357 shares — an estimated $86K sold.

Sentry Investment Management first reported a position in RMD in Q3 2017 and held it in 31 quarters. The position peaked at $1.95M in Q4 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Sentry Investment Management reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Sentry Investment Management sold 357 ResMed shares in Q1 2026, an estimated $86K.
  • Sentry Investment Management first reported a position in ResMed in Q3 2017 and held it in 31 quarters.
  • Sentry Investment Management's ResMed position peaked at $1.95M in Q4 2020.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.